The incidence of atherosclerosis and cardiovascular disease (CVD) in women increases following menopause and has been associated with a reduction in circulating estrogen. Increased CVD risk is also perpetuated by sedentary lifestyle. Growing evidence indicates that oxidation of lipoproteins leads to a powerful immune response, disruption of normal lipoprotein function, and deposition of atherosclerotic plaques. For example, once high-density lipoproteins (HDL) are oxidized, they lose the ability to a) participate in reverse transport of cholesterol to the liver, and b) protect low-density lipoproteins (LDL) against oxidation. The purpose of this study was to determine the effects of combining estrogen replacement and exercise upon lipid peroxidation of the HDL fraction (HDL-ox). Blood samples were drawn from 34 post-menopausal women from four groups: women who were not receiving estrogen replacement and who were sedentary (NSD) (n = 9); women who were not receiving estrogen replacement and who were participating in regular exercise (NEX) (n = 8); women who were receiving estrogen replacement and who were sedentary (ESD) (n = 8); and women who were receiving estrogen replacement and who were participating in regular exercise (EEX) (n = 9). Total-HDL cholesterol was significantly higher (p<0.05) in EEX when compared with NEX, NSD, and ESD. HDL-ox was assessed via malondialdehyde (MDA). Mean (± SEM) values for HDL MDA expressed in nM are as follows: NSD = 903.3 ± 118.4; NEX = 1226.7 ± 247.7; ESD = 876.7 ± 116.3; EEX = 537.4 ± 74.8. EEX lipid peroxidation was significantly (p = 0.02) lower than NEX. Lipid peroxidation tended to be lower in EEX than in NSD and ESD (p = 0.07). These data indicate that the combination of estrogen replacement and regular exercise in post-menopausal women may be most effective in reducing oxidation of HDL in vivo.
Key words
Atherosclerosis - cardiovascular disease - free radicals - high density lipoproteins - hormone replacement therapy
References
1
Ayres S, Tang M, Subbiah M T.
Estradiol-17ß as an antioxidant: some distinct features when compared with common fat-soluble antioxidants.
J Lab Clin Med .
1996;
128
367-375
2
Beard CM, Barnard R J, Robbins D C, Ordovas J M, Schaefer EJ.
Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation.
Arterioscl Thromb Vasc Bio.
1996;
16
201-207
3
Berliner J A, Naveb M, Fogelman A M, Frank J S, Demer L L, Edwardes P A, Watson A D, Lusis A J.
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.
Circulation.
1995;
91
2488-2496
4
Bowling N, Matter W F, Gadski R A, McClure D B, Schreyer T, Dawson P A, lahos O J.
LY295427, a novel hypocholesterolemic agent, enhances [3H]25-hydroxycholesterol binding to liver cytosolic proteins.
J Lipid Res.
1996;
37
2586-2598
5
Bowry V W, Stanley K K, Stocker R.
High density lipoprotein is the major carrier of hydroperoxides in human blood plasma from fasting donors.
Proc Natl Acad Sci.
1992;
89
10 316-10 320
6
Bruckert E, Turpin G.
Estrogens and progestins in post-menopausal women: influence on lipid parameters and cardiovascular risk.
Hormone Res.
1995;
43
100-103
8
Christison J K, Rye K A, Stocker R.
Exchange of oxidized cholesteryl linoleate between LDL and HDL by cholesterol ester transfer protein.
J Lipid Res.
1995;
36
2017-2026
11
de Waart F G, Moser U, Kok F J.
Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL.
Atherosclerosis.
1997;
133
255-263
12
Egeland G M, Kuller K H, Matthews K A, Kelsey S F, Cauley J, Guzick D.
Hormone replacement therapy and lipoprotein changes during early menopause.
Obstetr Gynecol.
1990;
76
776-782
13
Folsom A R, Mink P J, Sellers T A, Hong C P, Zheng W, Potter J D.
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women.
Am J Pub Health.
1995;
85
1128-1132
14
Fruebis J, Ginzalez V, Silvestre M, Palinski W.
Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF.
Arterioscl Thromb Vasc Biol.
1995;
17
1289-1302
16
Goldstein J L, Ho Y K, Basu S K, Brown M S.
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition.
Proc Natl Acad Soc USA.
1979;
76
333-337
17
Görög P.
Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for generation of lipid peroxides in circulation.
Int J Exp Pathol.
1991;
72
227-237
18
Gutteridge J MC, Quinlan G J.
Malondialdehyde formation in the thiobarbituric acid test: the role of lipid radicals, iron salts, and metal chelators.
J Appl Biochem.
1983;
5
293-299
19
Hahn M, Subbiah M T.
Significant association of lipid peroxidation products with high density lipoproteins.
Biochem Mol Biol Internat.
1994;
33
699-704
20
Heikkinen A M, Niskanen L, Yla-Herttuala S, Luoma J, Tuppruainen M T, Kamulainen M, Saarikoski S.
Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.
Maturitus.
1998;
29
155-161
22
Kanter M M, Hamlin R L, Unverferth D V, Davis H W, Merola A J.
Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin.
J Appl Physiol.
1986;
59
1298-1303
25
Lawler J M, Powers S K, Visser T, VanDijk H, Kordus M, Ji L L.
Acute exercise and skeletal muscle antioxidant and metabolic enzymes: effects of fiber-type and age.
Am J Physiol.
1993;
265
R1344-R1350
26
Mahfouz M M, Kawano H, Kummerow F A.
Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits.
Am J Clin Nutr.
1997;
66
1240-1249
27
Martin A, Frei B.
Both intracellular and extracellular Vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells.
Arterioscl Thromb Vasc Biol.
1997;
17
1583-1590
28
McManus J, McEneny J, Thompson W, Young L S.
The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Atherosclerosis.
1997;
135
73-81
29
McManus J, McEneny J, Young L S, Thompson W.
The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro.
Maturitus.
1996;
25
125-131
30
Mehta J L, Chen L Y.
Reversal of high-density lipoproteins of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets.
J Lab Clin Med.
1996;
127
287-295
31
Mena P, Maynar M, Gutierrez J M, Maynar J, Timon J, Campillo J E.
Erythrocyte free radical scavenger enzymes in bicycle professional racers: adaptation to exercise.
Int J Sports Med.
1991;
12
563-566
34
Ohmura H, Watanabe Y, Hatsumi C, Sato H, Daida H, Mokuno H, Yamaguchi H.
Possible role of high susceptibility of high-density lipoprotein to lipid peroxidative modification and oxidized high-density lipoprotein in genesis of coronary artery spasm.
Atherosclerosis.
1999;
142
179-184
35
Palinski W, Yla-Herttuala S, Rosenfeld M E, Butler S W, Socher S A, Parthasarathy S, Curtiss L K, Witztum J L.
Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Arteriosclerosis.
1990;
10
325-335
37
Panasenko O M, Vol'nova TV, Azizova OA, Vladimirov Y A.
Free radical modification of lipoproteins and cholesterol accumulation in cells upon atherosclerosis.
Free Rad Biol Med.
1991;
10
137-148
39
Powers S K, Criswell D, Lawler J M, Martin D, Lieu F K, Ji L L, Herb R.
Rigorous exercise training increases superoxide dismutase activity in the ventricular myocardium.
Am J Physiol.
1993;
265
H2094-H2098
40
Rifici V A, Khachadurian A K.
Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux.
Atherosclerosis.
1996;
127
19-26
41
Robertson J D, Maughan R J, Duthie G G, Morrice P C.
Increased blood antioxidant systems of runners in response to training load.
Clin Sci.
1991;
80
611-618
45
Suc I, Escargueil-Blanc I, Troly M, Salvayre R, Negre-Salvayre A.
HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL.
Arterioscl Thromb Vasc Biol.
1997;
17
2158-2166
46
Taichakraichana N, Limpaphayom K, Ninlagarn T, Panyakhamlerd K, Chaikittisilpa S, Dusitsin N.
A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
Obstetr Gynecol.
2000;
95
87-94
47
Vasankari T J, Kujala U M, Vasankari T M, Ahotupa M.
Reduced oxidized LDL levels after a 10-month exercise program.
Med Sci Sports Exer.
1998;
30
1496-1501
48
Wakatsuki A, Ikenoue N, Sagara Y.
Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.
Maturitus.
1998;
28
229-234
49
Wander R C, Du S H, Ketchum S D, Rowe K E.
Effects of interaction of RRR-alpha-tocopherol acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy.
Am J Clin Nutr.
1996;
63
184-193
50
Wells G, Herrington D M.
The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain.
Drugs Aging.
1999;
15
419-422
51
Wetzstein C J, Sherry-Brewer R A, Santanam N, Green N R, White-Welkley J E, Parthasarathy S.
Does acute exercise affect the susceptibility of low density lipoprotein to oxidation?.
Free Rad Biol Med.
1998;
24
679-682
